Indications for ROCKLATAN:
Open-angle glaucoma. Ocular hypertension.
Instill 1 drop into the affected eye(s) once daily in the PM.
Do not exceed recommended dose. Ocular inflammation; avoid if active. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Herpetic keratitis; avoid if active. Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.
Rho kinase inhibitor + prostaglandin analogue.
Allow at least 5mins between administration of thimerosal-containing oph drops or other topical oph agents. Concomitant additional prostaglandins or prostaglandin analogues: not recommended.
Conjunctival hyperemia, instillation site pain, corneal verticillata, conjunctival hemorrhage, eye pruritus, reduced visual acuity, increased lacrimation, instillation site discomfort, blurred vision; increased ocular pigmentation (eg, iris, eyelid, eyelashes; may be permanent), eyelash changes, bacterial keratitis.